Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | STAT3 | P40763 | 1/20 | 0.41 |
| ▸ | STAT1 | P42224 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 3/20 | 0.38 |
| ▸ | RAB9A | P51151 | 3/20 | 0.38 |
| ▸ | ESR1 | P03372 | 1/20 | 0.38 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.38 |
| ▸ | DYRK3 | O43781 | 1/20 | 0.38 |
| ▸ | CLK1 | P49759 | 1/20 | 0.38 |
| ▸ | CLK2 | P49760 | 1/20 | 0.38 |
| ▸ | CLK3 | P49761 | 1/20 | 0.38 |
| ▸ | GSK3B | P49841 | 1/20 | 0.38 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.38 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.38 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.38 |
| ▸ | DYRK2 | Q92630 | 1/20 | 0.38 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.38 |
| ▸ | DYRK1B | Q9Y463 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4413776 | 0.90 | TOP1 (0.53) | STAT3STAT1TOP1CYCS | |
| SCHEMBL16270682 | 0.88 | CYCS (0.54) | STAT3STAT1TOP1CYCS | |
| SCHEMBL7260971 | 0.87 | MAPT (0.36) | STAT3STAT1ESR1ESR2KDM4E | |
| SCHEMBL8676967 | 0.82 | STAT3 (0.46) | STAT3STAT1TOP1CYCS | |
| SCHEMBL19901985 | 0.82 | TOP1 (0.60) | STAT3STAT1TOP1CYCS | |
| SCHEMBL19326350 | 0.82 | TOP1 (0.49) | STAT3STAT1TOP1CYCS | |
| SCHEMBL2673225 | 0.80 | STAT3 (0.50) | STAT3STAT1NPC1RAB9AESR1 | |
| SCHEMBL16923752 | 0.79 | TOP1 (0.46) | STAT3STAT1TOP1CYCS | |
| SCHEMBL17934754 | 0.79 | TOP1 (0.75) | STAT3STAT1KDM4EALDH1A1TOP1 | |
| SCHEMBL14181439 | 0.79 | STAT3 (0.46) | STAT3STAT1TOP1CYCS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 137 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3265120-B1 | METHOD | PCI BIOTECH AS (NO) | 2023-07-05 | — | — | EP | claimed |
| US-11648287-B2 | Composition for the treatment of intracellular bacterial infection | ACADEMISCH MEDISCH CENTRUM (NL) | 2023-05-16 | — | — | US | claimed |
| US-7157432-B2 | Tetraphenylbacteriochlorin derivatives and compositions containing the same | SAN-EI GEN F.F.I., INC. (JP) | 2007-01-02 | — | — | US | claimed |
| US-20060003946-A1 | Tissue-penetrating property, and exhibits high selectivity to tumor cells and hydrophilicity | REI MEDICAL CO., LTD. (JP) | 2006-01-05 | — | — | US | claimed |
| EP-1316558-B9 | TETRAPHENYLBACTERIOCHLORIN DERIVATIVES AND COMPOSITIONS CONTAINING THE SAME | SAN EI GEN FFI INC (JP) | 2005-12-07 | — | — | EP | claimed |
| US-6958389-B2 | Tetraphenylbacteriochlorin derivatives and compositions containing the same | SAN-EI GEN F.F.I. INC. (JP) | 2005-10-25 | — | — | US | claimed |
| EP-1316558-B1 | TETRAPHENYLBACTERIOCHLORIN DERIVATIVES AND COMPOSITIONS CONTAINING THE SAME | SAN EI GEN FFI INC (JP) | 2005-08-17 | — | — | EP | claimed |
| US-20030171305-A1 | Tetraphenylbacteriochlorin derivatives and compositions containing the same | REI MEDICAL CO., LTD. (JP) | 2003-09-11 | — | — | US | claimed |
| EP-1316558-A1 | TETRAPHENYLBACTERIOCHLORIN DERIVATIVES AND COMPOSITIONS CONTAINING THE SAME | SAN-EI GEN F.F.I., INC. (JP) | 2003-06-04 | — | — | EP | claimed |
| US-20240115731-A1 | METHOD OF DELIVERING MRNA IN VIVO | PCI BIOTECH AS (NO) | 2024-04-11 | — | — | US | disclosed |
| WO-2024068795-A1 | METHOD FOR RELEASING VIRAL VECTORS | PCI BIOTECH AS (NO) | 2024-04-04 | — | — | WO | disclosed |
| EP-3743110-B1 | MRNA MOLECULE AND PHOTOSENSITIZING AGENT FOR MEDICAL USE | PCI BIOTECH AS (NO) | 2024-01-10 | — | — | EP | disclosed |
| EP-4288065-A1 | METHOD OF DELIVERING MRNA IN VIVO | PCI Biotech AS (NO) | 2023-12-13 | — | — | EP | disclosed |
| CN-116981464-A | Methods for in vivo delivery of mRNA | PCI生物技术有限公司 | 2023-10-31 | — | — | CN | disclosed |
| US-6420648-B1 | SOLAR CELLS | NORTH CAROLINA STATE UNIVERSITY | 2002-07-16 | — | — | US | disclosed |
| US-6407330-B1 | A CIRCUIT ELECTRICALLY COUPLED TO SAID SOLAR CELL; LIGHT HARVESTING RODS OF NON-DISCOTIC BACKBONE POLYMER CONTAINING CHROMOPHORE GROUPS | NORTH CAROLINA STATE UNIVERSITY | 2002-06-18 | — | — | US | disclosed |
| WO-2002020536-A1 | TETRAPHENYLBACTERIOCHLORIN DERIVATIVES AND COMPOSITIONS CONTAINING THE SAME | SAN-EI GEN F.F.I.,INC. (JP) | 2002-03-14 | — | — | WO | disclosed |
| WO-2002009196-A1 | LIGHT HARVESTING ARRAYS | NORTH CAROLINA STATE UNIVERSITY (US) | 2002-01-31 | — | — | WO | disclosed |
| WO-2002009197-A1 | SOLAR CELLS INCORPORATING LIGHT HARVESTING ARRAYS | NORTH CAROLINA STATE UNIVERSITY (US) | 2002-01-31 | — | — | WO | disclosed |
| US-6123923-A | ADMINISTERING A PATIENT A CONTRAST AGENT CONTAINING A STABILIZER, A PHOTOACTIVE AGENT, A GASEOUS PRECURSOR SUCH AS PERFLUORINATED COMPOUND OR GAS OR BOTH, AND SCANNING THE PATIENT USING ULTRASOUND IMAGING AND OPTICAL IMAGING | IMARX PHARMACEUTICAL CORP. (US) | 2000-09-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030171305-A1 | Tetraphenylbacteriochlorin derivatives and compositions containing the same | SCNN1B, SLC7A1, MGMT | STAT3 2801/4885STAT1 2660/4885NPC1 4537/4885 |
| US-20240115731-A1 | METHOD OF DELIVERING MRNA IN VIVO | NSUN2, LCP1, NSUN3 | STAT3 240/4885STAT1 196/4885NPC1 908/4885 |
| US-20060003946-A1 | Tissue-penetrating property, and exhibits high selectivity to tumor cells and hydrophilicity | CD68, SLC7A1, SLC11A2 | STAT3 1848/4885STAT1 1190/4885NPC1 4200/4885 |
| US-11648287-B2 | Composition for the treatment of intracellular bacterial infection | ACTB, NFATC1, IFNG | STAT3 821/4885STAT1 359/4885NPC1 2749/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.